Back to VA VANGUARD CAPITAL MANAGEMENT LLC
FDMT2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in 4D MOLECULAR THERAPEUTICS IN
VANGUARD CAPITAL MANAGEMENT LLC holds 2.1M shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $27.9M as of 2026-Q2. The position was decreased (-4.4% shares). FDMT represents 0.0% of VANGUARD CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$27.9M
Current Shares
2.1M
Total Value Change
+$7.5M
Total Shares Change
-96,523
Quarter-by-Quarter History
Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Finance, Inc.